Product NDC: | 60505-0026 |
Proprietary Name: | Ranitidine |
Non Proprietary Name: | ranitidine hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; ranitidine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0026 |
Labeler Name: | Apotex Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074680 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970913 |
Package NDC: | 60505-0026-2 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0026-2) |
NDC Code | 60505-0026-2 |
Proprietary Name | Ranitidine |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0026-2) |
Product NDC | 60505-0026 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ranitidine hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19970913 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |